Cellunax works through transdermal delivery, a method that allows botanical ingredients to bypass the digestive system and absorb directly through the skin. Here is the full mechanism explained simply.
Transdermal delivery is the process of delivering active compounds through the skin rather than through the digestive system. This method is well established in both pharmaceutical and supplement contexts. Nicotine patches, hormone patches, and pain relief patches all use the same fundamental mechanism.
For berberine specifically, transdermal delivery offers two practical advantages over oral supplementation. First, it avoids first-pass liver metabolism, which breaks down a portion of oral berberine before it can exert its effects on metabolic pathways. Second, it removes the digestive discomfort associated with high-dose oral berberine, which is one of the most commonly reported complaints among users of berberine capsules.
Research indexed on PubMed has documented the feasibility of transdermal delivery for botanical alkaloids, with skin penetration profiles varying based on the carrier system used. The glycerin and mineral oil in Cellunax serve as penetration-supporting carriers.
The patch adheres to clean, dry skin. The adhesive layer keeps the formula in close contact with the skin surface throughout the wear period, essential for consistent ingredient transfer.
Within 15 to 30 minutes of application, the botanical compounds begin moving through the outer skin layers. Glycerin hydrates the skin to support this process. Mineral oil helps maintain even ingredient distribution across the patch surface.
Peony root extract interacts with skin receptors in the application area, producing the warming sensation users notice within the first hour. Local blood flow increases gently in response.
Berberine is released slowly from the patch matrix throughout the wear period. This slow-release profile provides consistent metabolic pathway exposure rather than the peak-and-trough pattern of once-daily oral dosing.
Berberine is the primary functional compound in Cellunax from a metabolic standpoint. Research published in the National Library of Medicine has documented berberine's ability to activate AMP-activated protein kinase (AMPK), an enzyme involved in cellular energy regulation. AMPK activation is associated with improved metabolic signalling and is one of the mechanisms by which GLP-1 agonist medications exert their metabolic effects.
Berberine's effect on these pathways builds with consistent daily exposure. This is why Cellunax users who see the best results are those who use the patch every day for at least 6 to 8 weeks before evaluating outcomes. For more on the GLP-1 connection, see the Cellunax GLP-1 support page.
Standard warming patches available at pharmacies use counter-irritant compounds such as menthol or capsaicin to create surface heat. This is a localised sensory effect with no metabolic pathway activity.
Cellunax combines the warmth mechanism of peony root with berberine's documented metabolic pathway activity. The warming effect and the metabolic support work through different mechanisms simultaneously during the wear period. This dual-action approach differentiates Cellunax from single-purpose warming products and single-ingredient berberine patches.
For practical application guidance, see the Cellunax patches page.
Ready to try the Cellunax transdermal delivery system? Order from the official website today.
Visit the Official Cellunax WebsiteCellunax is a herbal transdermal patch that delivers berberine and peony root extract through the skin over an 8-hour wear period. Berberine interacts with AMPK and GLP-1 associated metabolic pathways over time, supporting appetite regulation. Peony root extract produces immediate warming and comfort in the applied area. Glycerin and mineral oil support skin penetration and ingredient delivery. The formula bypasses the digestive system, avoiding the discomfort associated with oral berberine supplementation. Available exclusively at cellunax-us.com.